fbpx
Gabriel Loor, MD

Dr. Loor’s mission is to provide hope and cures for patients with advanced heart and lung disease through clinical excellence, research, leadership and education. Through his training and experience he has gained significant expertise in routine and complex adult cardiac surgery and is committed to quality improvement and best practices to make a positive difference in patients’ lives. Show full bio

Dr. Loor is passionate about maximizing donor organs for lung transplant recipients given the high mortality of patients on the waitlist and a shortage of donor organs. He has successfully initiated portable ex vivo lung perfusion (EVLP) research and clinical programs and is credited with the first “breathing lung” transplant in the Midwest and in Texas.

Dr. Loor received his cardiac surgical and transplant training at Cleveland Clinic, after which he spent several years at the University of Minnesota as assistant professor in cardiac surgery, surgical director of the lung transplant program, co-director of the aortic program and co-director of the adult congenital program. There he significantly increased the volume and quality of lung transplantation through donor utilization and launched the acute aortic emergency program.

Presently, as surgical director of the lung transplant program at Baylor College of Medicine, Dr. Loor’s goal is to lead the world’s largest and highest quality lung transplant program. He also offers and supports the highest standards of clinical excellence and quality in cardiac surgery. Dr. Loor specializes in both routine and complex adult cardiac surgery as well as surgery for advanced heart and lung failure. He also participates in the interventional program for mitral valve and aortic valve disease where minimally invasive techniques are used to avoid open surgery. Dr. Loor’s research interests focus on improving donor utilization and surgical outcomes through basic and translational science collaborations and participation in outcomes registries and clinical trials. Dr. Loor chairs the Cardiovascular Quality Initiative group at Baylor St. Luke’s which seeks to optimize patient outcomes through multidisciplinary collaboration.

See Publications

Education

  • Undergraduate:

    University of Miami (Biochemistry)

  • Medical School:

    Northwestern University, Feinberg School of Medicine

  • Internship:

    University of Chicago Hospitals

  • Residency:

    University of Chicago Hospitals
    Cleveland Clinic

  • Fellowships:

    University of Chicago Hospitals

Academic & Clinical Affiliations

Certifications

  • American Board of Thoracic Surgery
  • American Board of Surgery

Publications

Subramaniam, K., Loor, G., Chan, E. G. et al. (2023). Intraoperative red blood cell transfusion and primary graft dysfunction after lung transplantation. Transplantation. https://doi.org/10.1097/TP.0000000000004545.
Sawinski, D., Lai, J. C., Pinney, S. et al. (2023). Addressing sex-based disparities in solid organ transplantation in the United States - a conference report. Am J Transplant 23, 316–325. https://doi.org/10.1016/j.ajt.2022.11.008.
Chacon-Alberty, L., Fernandez, R., Jindra, P. et al. (2023). Primary graft dysfunction in lung transplantation: a review of mechanisms and future applications. Transplantation. https://doi.org/10.1097/TP.0000000000004503.
Sylvester, C. B., Patel, V., Ghanta, R. K. et al. (2022). Considerations for left atrial appendage occlusion during cardiac surgery. Cardiovasc Drugs Ther. https://doi.org/10.1007/s10557-022-07415-y.
Letsou, G. V., Musfee, F. I., Zhang, Q. et al. (2022). Stroke and mortality rates after off-pump vs. pump-assisted/no-clamp coronary artery bypass grafting. J Cardiovasc Surg (Torino) 63, 742–748. https://doi.org/10.23736/S0021-9509.22.12337-2.
Chacon-Alberty, L., Ye, S., Elsenousi, A. et al. (2022). Effect of intraoperative support mode on circulating inflammatory biomarkers after lung transplantation surgery. Artif Organs. https://doi.org/10.1111/aor.14474.
Chacon-Alberty, L., Kanchi, R. S., Ye, S. et al. (2022). Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis. Sci Rep 12, 16137. https://doi.org/10.1038/s41598-022-20085-y.
Richards, K., Li, G., Segraves, J. et al. (2022). A 76-year-old man with exertional hypoxemia after left single lung transplantation. Ann Am Thorac Soc 19, 1591–1595. https://doi.org/10.1513/AnnalsATS.202202-172CC.
Miggins, J. J., Reul, R. M., Loor, G. et al. (2022). Trends in marginal lung allograft survival: Advanced-age donors improve. Clin Transplant, e14777. https://doi.org/10.1111/ctr.14777.
Kumar, A., Li, G. W., Segraves, J. M. et al. (2022). Pediatric lung transplantation for COVID-19: Unique clinical and psychosocial barriers. Pediatr Transplant, e14351. https://doi.org/10.1111/petr.14351.

Recent News

Creative Strategies Used to Save COVID Patient Who Needed 149 Days of Extracorporeal Membrane Oxygenation

Infection with COVID-19 can take many forms. It can be mild enough to be mistaken for the common cold, or...

The Texas Heart Institute Journal’s Global Outreach

Since its founding in 1962, The Texas Heart Institute has remained dedicated to improving cardiovascular care worldwide through international collaboration,...

The Texas Heart Institute Makes a Strong Showing at ISHLT 2023

Daniel Timms, PhD, founder and chief technical officer of BiVACOR, Inc., described the benchtop testing and preclinical studies performed with...